MILLENNIUM MANAGEMENT LLC

Position in ASND — Ascendis Pharma A/S

CIK 1273087 NEW YORK, NY

Back to ASND Full portfolio

Position in ASND

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$43,236,145

-$12,702,890 QoQ

Shares Held

189,027

-27.9% QoQ

Ownership

0.288%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

23 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ASND Over Time

Shares Held

Position Value (USD)

Derivatives in ASND

reported options exposure · as of Dec 31, 2025

CallValue

$533,100

CallShares

2,500

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MILLENNIUM MANAGEMENT LLC holds $4,565,450,068 across 341 Biotechnology names. ASND ranks #23 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	1,262,511	$238,677,704
2	INSM	INSMED Inc	1,157,786	$189,321,166
3	BMRN	Biomarin Pharmaceutical Inc	3,010,308	$170,052,298
4	TERN	Terns Pharmaceuticals, Inc.	3,011,558	$158,769,337
5	ALNY	Alnylam Pharmaceuticals, Inc.	447,887	$148,192,371
6	FOLD	AMICUS THERAPEUTICS, INC.	7,908,459	$114,356,317
7	ARDX	Ardelyx, Inc.	17,842,370	$106,875,796
8	BLTE	Belite Bio, Inc	570,088	$90,894,830

All Filings in ASND

Export CSV

39 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$43,236,145	189,027	+7461.1%	Shares	Sole	2026-05-15
2025-12-31	$533,100	2,500	-99.0%	Call	Sole	2026-02-17
2025-12-31	$55,939,035	262,329	+50.2%	Shares	Sole	2026-02-17
2025-09-30	$34,712,822	174,603	+773.0%	Shares	Sole	2025-11-14
2025-09-30	$3,976,200	20,000	-13.0%	Put	Sole	2025-11-14
2025-09-30	$4,572,630	23,000	-68.4%	Call	Sole	2025-11-14
2025-06-30	$12,580,468	72,888	+1357.8%	Shares	Sole	2025-08-14
2025-03-31	$779,300	5,000	-50.0%	Call	Sole	2025-05-15
2025-03-31	$1,558,600	10,000	-96.2%	Put	Sole	2025-05-15
2025-03-31	$41,282,170	264,867	-26.0%	Shares	Sole	2025-05-15
2024-12-31	$49,305,684	358,144	+842.5%	Shares	Sole	2025-02-14
2024-09-30	$5,673,780	38,000	-92.4%	Put	Sole	2024-11-14
2024-09-30	$74,907,333	501,690	+6.0%	Shares	Sole	2024-11-14
2024-06-30	$64,568,974	473,449	+30.8%	Shares	Sole	2024-08-14
2024-03-31	$54,732,610	362,060	+382.7%	Shares	Sole	2024-05-15
2024-03-31	$11,337,750	75,000	+235.0%	Call	Sole	2024-05-15
2023-12-31	$2,820,146	22,391	-47.7%	Shares	Sole	2024-02-14
2023-09-30	$4,012,661	42,852	+469.5%	Shares	Sole	2023-11-14
2022-12-31	$918,906	7,524	-79.2%	Shares	Sole	2023-02-14
2022-09-30	$3,738,012	36,200	+36.4%	Call	Sole	2022-11-14
2022-09-30	$2,739,797	26,533	-59.1%	Shares	Sole	2022-11-14
2022-06-30	$6,035,242	64,923	+85.5%	Shares	Sole	2022-08-15
2022-06-30	$3,253,600	35,000	-77.7%	Call	Sole	2022-08-15
2022-03-31	$18,444,767	157,164	+214.3%	Shares	Sole	2022-05-16
2022-03-31	$5,868,000	50,000	+233.3%	Call	Sole	2022-05-16
2021-12-31	$2,017,950	15,000	-88.1%	Call	Sole	2022-02-14
2021-12-31	$16,896,429	125,596	+737.3%	Shares	Sole	2022-02-14
2021-09-30	$2,390,850	15,000	-91.9%	Call	Sole	2021-11-15
2021-09-30	$29,388,965	184,384	+426.8%	Shares	Sole	2021-11-15
2021-06-30	$4,604,250	35,000	+312.8%	Call	Sole	2021-08-16
2021-06-30	$1,115,280	8,478	-87.7%	Shares	Sole	2021-08-16
2021-03-31	$8,894,008	69,010	+721.5%	Shares	Sole	2021-05-17
2021-03-31	$1,082,592	8,400	-90.2%	Call	Sole	2021-05-17
2020-12-31	$14,341,578	85,991	+60.1%	Shares	Sole	2021-02-16
2020-12-31	$8,956,086	53,700	-55.7%	Call	Sole	2021-02-16
2020-09-30	$18,724,880	121,338	-41.6%	Shares	Sole	2020-11-16
2020-06-30	$30,706,702	207,618	+347.5%	Shares	Sole	2020-08-14
2020-06-30	$6,862,560	46,400	-82.8%	Call	Sole	2020-08-14
2020-03-31	$30,413,370	270,077	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.